10-Q · May 5, 2026
Horizon Technology Finance reported Q1 2026 results with revenues of $24.1 million, outperforming estimates while EPS met expectations at $0.19. With total investment income reflecting a slight decrease of 1.8%…
Earnings analysis · 10-Q
HRZN earnings analysis
Filed August 4, 2026 · Our reading of the company's report
The latest report
Q2 investment income increased 2.1% year over year to $25.045 million and reported EPS was $0.11, but a $38.533 million unrealized depreciation charge and $4.4 million of merger expenses materially pressured results.…
Read full summary
Q2 investment income increased 2.1% year over year to $25.045 million and reported EPS was $0.11, but a $38.533 million unrealized depreciation charge and $4.4 million of merger expenses materially pressured results. Net investment income fell to $7.393 million from $11.449 million a year earlier as expenses increased 36.9% to $17.387 million. Liquidity and operating cash generation improved, but increased PIK income, lower portfolio yield and a sizable pool of rating-4 and rating-5 credits underpin a bearish trend assessment.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.11
What stood out
-
Investment income continued modest growth
Total investment income rose 2.1% year over year to $25.045 million from $24.520 million, and increased about 4.0% sequentially from $24.079 million in Q1 2026 (derived from $49.124 million first-half income less $25.045 million Q2 income). Interest income increased 5.7% to $23.9 million as average earning debt investments rose 6.7% to $652.3 million.
-
Portfolio expanded despite repayments
Portfolio fair value increased to $676.711 million at June 30 from $647.244 million at December 31. Q2 originations of $72.762 million exceeded the $47.123 million of principal payments, early payoffs and paydowns, before valuation changes.
-
Cash generation and deleveraging improved
Liquidity remained meaningful: cash and money-market investments were $132.3 million, while total debt outstanding net of issuance costs fell to $402.443 million from $473.027 million at year-end. Operating activities generated $81.4 million of cash in the first six months, versus $36.4 million a year earlier.
-
Share repurchases deployed at discount
The company repurchased 1,365,222 shares for $6.2 million at an average $4.54 per share in Q2. Subsequently, on August 3, the Board increased the repurchase authorization to $20.0 million.
-
Senior loan exposure and key sectors grew
Asset mix shifted toward senior lending: Senior Term Loans represented 97.7%, or $633.3 million, of debt investments at fair value. Software debt investments grew $38.473 million to $224.007 million and biotechnology grew $24.702 million to $82.455 million versus year-end.
What to watch
-
Valuation losses accelerated sharply
Net unrealized depreciation was $38.533 million in Q2, worsening from $22.156 million a year earlier, and drove a $37.262 million net decrease in net assets from operations versus a $20.777 million decrease in the prior-year quarter.
-
Stressed-credit exposure increased
Five rating-5 credits had $58.0 million of cost but only $31.3 million of fair value, while four rating-4 credits had $57.1 million of cost and $48.0 million of fair value. Management attributed deterioration to low portfolio-company cash, difficult equity fundraising and underperformance.
-
Income quality weakened and yields declined
Non-cash PIK interest rose 544.4% to $1.6 million and represented 6.3% of Q2 investment income, versus 1.0% a year earlier. Debt-investment yield also declined to 14.9% from 15.8%.
-
Large unfunded commitments pressure liquidity
Unfunded commitments were $153.516 million at June 30, including $16.6 million of undrawn revolver commitments, compared with $132.3 million of cash and money-market investments. These commitments could require future liquidity deployment despite milestone conditions.
-
Risk-factor update: Middle East conflict
The sole disclosed material risk-factor update for the six months ended June 30, 2026 concerned Middle East conflicts, including Israel and Iran. Management said the conflicts create material uncertainty for the company and portfolio companies; this sits alongside $153.516 million of unfunded commitments requiring continued access to capital.
Management's outlook
No quantitative revenue or EPS outlook was provided in the 10-Q. Management stated that current cash, operating cash flow and Credit Facility availability are expected to meet working-capital and capital-expenditure commitments for at least the next 12 months. The Advisor agreed to waive $4.0 million of fees, at $1.0 million per quarter, from Q3 2026 through Q2 2027.
Earlier filings 4
10-K · April 30, 2026
Horizon Technology Finance Corporation merged with Monroe Capital in April 2026, receiving $141 million in cash and issuing 20.37 million shares. The merger's completion may position HRZN to leverage combined assets,…
10-K · March 3, 2026
Horizon Technology Finance remains a venture-lending BDC focused on secured debt to development-stage technology, life science, healthcare information and sustainability companies. As of December 31, 2025 the company…
10-Q · October 28, 2025
Horizon Technology Finance reported a stronger quarter with total investment income of $26,318 (thousands) vs $24,563 in the prior-year quarter and net investment income of $13,993 (thousands) vs $11,837, while…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.